U
About
Prime Medicine was founded with the mission of transforming patient lives through its groundbreaking Prime Editing platform. Unlike earlier gene editing technologies, Prime Editing functions as a molecular 'search and replace' tool—precisely locating disease-causing mutations in the genome and substituting them with a correct DNA sequence, all without inducing double-strand DNA breaks that can lead to unintended edits. The platform is designed to be versatile, precise, and efficient, theoretically capable of addressing approximately 90% of known disease-causing mutations across a wide range of organs, cell types, and organisms. Prime Medicine's proprietary innovations—including its Dual Flap and PASSIGE delivery approaches—further extend the reach and efficiency of Prime Editing in clinically relevant tissues. Prime Medicine is advancing a growing pipeline of clinical programs targeting serious genetic diseases, with a commitment to patients and caregivers throughout the development process. The company combines deep scientific expertise with cutting-edge molecular biology to push the frontier of what is achievable in gene editing. It is backed by leading investors and collaborates with scientific founders and advisors at the forefront of genome science. Prime Medicine represents a new generation of genetic medicine companies seeking to deliver lasting, potentially life-long cures rather than symptom management.
Key Features
- Search-and-Replace Gene Editing: Prime Editing locates the precise genomic location of a disease-causing mutation and replaces faulty DNA with a correct copy, analogous to a word processor's find-and-replace function.
- No Double-Strand DNA Breaks: Unlike CRISPR-Cas9 and other nuclease-based tools, Prime Editing does not induce double-strand DNA breaks, significantly reducing the risk of unintended genomic alterations.
- Broad Mutation Coverage: The platform is theoretically capable of addressing ~90% of known disease-causing mutations across diverse cell types, tissues, and organisms.
- Proprietary Delivery Innovations: Prime Medicine's Dual Flap and PASSIGE technologies enhance the efficiency and reach of Prime Editing in clinically relevant tissues.
- Growing Clinical Pipeline: Prime Medicine is advancing multiple clinical programs targeting severe genetic diseases, including pre-screening studies such as Prime-0211.
Use Cases
- Developing curative gene therapies for patients with rare monogenic diseases caused by point mutations or small insertions/deletions.
- Correcting disease-causing genetic variants in blood disorders, metabolic diseases, and other heritable conditions.
- Advancing research programs that require highly precise, scarless genome edits at the endogenous genomic locus.
- Partnering with academic institutions and biopharmaceutical companies to apply Prime Editing to new therapeutic targets.
- Pre-screening patients with specific genetic mutations for enrollment in Prime Medicine clinical trials.
Pros
- Highly Precise Editing: The platform's search-and-replace mechanism delivers targeted corrections with minimal off-target effects compared to earlier gene editing approaches.
- Wide Therapeutic Applicability: Capable of addressing the vast majority of known genetic mutations, offering potential treatments across a broad spectrum of rare and common diseases.
- Potentially Curative Outcomes: By correcting the genetic root cause of disease rather than managing symptoms, Prime Editing aims to provide patients with durable, life-long benefit.
Cons
- Early Clinical Stage: Most programs are still in early clinical or pre-clinical development, so long-term safety and efficacy data in humans remain limited.
- Delivery Complexity: Delivering Prime Editing machinery efficiently to target tissues in vivo remains a significant scientific and engineering challenge.
Frequently Asked Questions
What is Prime Editing?
Prime Editing is a next-generation gene editing technology that acts like a DNA word processor. It searches for a specific disease-causing sequence in the genome and replaces it with the correct DNA sequence—without causing double-strand DNA breaks.
How is Prime Editing different from CRISPR?
Traditional CRISPR-Cas9 cuts both strands of DNA, which can introduce errors during repair. Prime Editing avoids double-strand breaks entirely, enabling more precise and predictable edits with a lower risk of unintended mutations.
What diseases can Prime Medicine's platform address?
The Prime Editing platform is theoretically capable of addressing approximately 90% of known disease-causing mutations, spanning a wide range of genetic diseases across many organs and cell types.
Where is Prime Medicine in its clinical development?
Prime Medicine is advancing a growing pipeline of programs, including clinical-stage initiatives such as the Prime-0211 pre-screening study, with ongoing updates provided through investor and scientific communications.
Who founded Prime Medicine?
Prime Medicine was founded by leading scientists in the gene editing field and is guided by a scientific advisory board and board of directors with deep expertise in genomics, medicine, and drug development.
